Livzon Group: The company has recently submitted all the information on the vaccine application for conditional listing to the review department_Oriental Fortune Network

Every time an AI Express is sent, an investor asks a question on the investor interaction platform: Please speed up the progress of the company, not every hot spot is “declaring”, such as test kits, vaccines and other hot spots. Are there any new developments in vaccines? Under the circumstance that the national policy is inclined to accelerate, the company is requested to respond more actively, and communicate and exchange opinions with relevant departments.

　　Livzon Group(000513.SZ) stated on the investor interaction platform on April 2 that in terms of domestic application, we have recently submitted all the materials for the application for conditional listing to the review department. The progress of vaccine approval is subject to the existing review policies and reviews. Due to the impact of the approval progress of the evaluation department, we also look forward to the early listing of V-01 to contribute to the country’s anti-epidemic efforts. In terms of overseas declarations, we are also actively communicating with regulatory agencies in many countries at the same time to clarify the route for marketing declaration of vaccines, including countries that have conducted Phase III clinical trials, but not limited to these countries. The company also cooperates with some well-known local pharmaceutical companies to promote to local regulatory medical institutions, and is currently actively preparing for EUA or listing applications.

(Article source: Daily Economic News)

Article source: Daily Economic News

Responsible editor: 92

Original title: Livzon Group: The company has recently submitted all the information on the vaccine application for conditional listing to the review department